Insmed Inc Stock Z Score

INSM Stock  USD 27.32  0.30  1.11%   
Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Insmed Piotroski F Score and Insmed Valuation analysis.
  
At this time, Insmed's Capital Surpluse is very stable compared to the past year. As of the 28th of March 2024, Capital Expenditures is likely to grow to about 14 M, while Net Working Capital is likely to drop about 667.3 M. At this time, Insmed's Total Operating Expenses is very stable compared to the past year. As of the 28th of March 2024, Income Tax Expense is likely to grow to about 2.7 M, though EBIT is likely to grow to (650.3 M).

Insmed Z Score Analysis

Insmed's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

 = 

Sum Of

5 Factors

More About Z Score | All Equity Analysis

Current Insmed Z Score

    
  -2.41  
Most of Insmed's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Insmed Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

First Factor

 = 

1.2 * (

Working Capital

/

Total Assets )

Second Factor

 = 

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

 = 

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

 = 

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

 = 

0.99 * (

Revenue

/

Total Assets )

Insmed Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Insmed is extremely important. It helps to project a fair market value of Insmed Stock properly, considering its historical fundamentals such as Z Score. Since Insmed's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Insmed's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Insmed's interrelated accounts and indicators.
0.86-0.340.59-0.960.920.610.940.970.950.990.90.890.870.880.540.91-0.680.91-0.110.95-0.490.970.440.930.60.950.930.93
0.86-0.70.87-0.940.960.890.750.890.950.830.710.830.870.910.390.78-0.680.93-0.080.95-0.70.910.260.960.480.740.740.89
-0.34-0.7-0.930.5-0.57-0.89-0.18-0.36-0.62-0.3-0.14-0.38-0.51-0.530.09-0.340.39-0.610.21-0.620.88-0.410.29-0.66-0.05-0.25-0.31-0.53
0.590.87-0.93-0.730.780.970.480.630.810.540.390.640.680.760.130.6-0.570.83-0.230.81-0.850.67-0.090.840.210.490.510.74
-0.96-0.940.5-0.73-0.97-0.75-0.92-0.99-0.97-0.94-0.88-0.86-0.93-0.9-0.49-0.940.66-0.970.06-0.960.54-0.99-0.43-0.96-0.63-0.84-0.83-0.94
0.920.96-0.570.78-0.970.790.870.950.960.90.810.820.90.880.410.88-0.750.95-0.070.95-0.60.950.340.950.540.80.80.93
0.610.89-0.890.97-0.750.790.470.660.810.570.430.630.710.780.220.59-0.520.82-0.140.8-0.780.690.010.840.210.460.480.73
0.940.75-0.180.48-0.920.870.470.960.840.930.90.830.830.750.460.97-0.650.86-0.060.84-0.270.950.560.820.680.870.810.86
0.970.89-0.360.63-0.990.950.660.960.930.960.910.860.920.880.540.95-0.640.93-0.020.93-0.421.00.520.920.650.860.830.91
0.950.95-0.620.81-0.970.960.810.840.930.930.790.870.90.920.420.88-0.70.97-0.161.0-0.70.950.271.00.520.870.880.95
0.990.83-0.30.54-0.940.90.570.930.960.930.910.840.880.840.520.9-0.640.88-0.090.93-0.450.950.460.910.620.940.930.9
0.90.71-0.140.39-0.880.810.430.90.910.790.910.730.820.740.60.85-0.530.780.080.79-0.250.890.610.770.740.820.80.84
0.890.83-0.380.64-0.860.820.630.830.860.870.840.730.690.930.50.78-0.740.87-0.180.86-0.510.880.340.850.460.880.820.89
0.870.87-0.510.68-0.930.90.710.830.920.90.880.820.690.760.370.87-0.430.880.180.9-0.520.920.440.90.740.730.740.82
0.880.91-0.530.76-0.90.880.780.750.880.920.840.740.930.760.650.74-0.680.9-0.110.91-0.650.870.310.910.40.820.80.89
0.540.390.090.13-0.490.410.220.460.540.420.520.60.50.370.650.37-0.220.390.090.41-0.140.460.450.390.30.480.460.42
0.910.78-0.340.6-0.940.880.590.970.950.880.90.850.780.870.740.37-0.60.91-0.110.87-0.370.950.450.860.660.810.780.86
-0.68-0.680.39-0.570.66-0.75-0.52-0.65-0.64-0.7-0.64-0.53-0.74-0.43-0.68-0.22-0.6-0.70.45-0.690.51-0.660.0-0.69-0.14-0.74-0.71-0.8
0.910.93-0.610.83-0.970.950.820.860.930.970.880.780.870.880.90.390.91-0.7-0.150.96-0.640.950.30.970.490.810.80.94
-0.11-0.080.21-0.230.06-0.07-0.14-0.06-0.02-0.16-0.090.08-0.180.18-0.110.09-0.110.45-0.15-0.170.29-0.040.5-0.160.41-0.21-0.2-0.19
0.950.95-0.620.81-0.960.950.80.840.931.00.930.790.860.90.910.410.87-0.690.96-0.17-0.710.940.271.00.520.870.890.95
-0.49-0.70.88-0.850.54-0.6-0.78-0.27-0.42-0.7-0.45-0.25-0.51-0.52-0.65-0.14-0.370.51-0.640.29-0.71-0.450.32-0.73-0.11-0.51-0.59-0.64
0.970.91-0.410.67-0.990.950.690.951.00.950.950.890.880.920.870.460.95-0.660.95-0.040.94-0.450.490.940.640.860.830.92
0.440.260.29-0.09-0.430.340.010.560.520.270.460.610.340.440.310.450.450.00.30.50.270.320.490.250.470.30.240.25
0.930.96-0.660.84-0.960.950.840.820.921.00.910.770.850.90.910.390.86-0.690.97-0.161.0-0.730.940.250.50.840.850.94
0.60.48-0.050.21-0.630.540.210.680.650.520.620.740.460.740.40.30.66-0.140.490.410.52-0.110.640.470.50.540.510.54
0.950.74-0.250.49-0.840.80.460.870.860.870.940.820.880.730.820.480.81-0.740.81-0.210.87-0.510.860.30.840.540.990.9
0.930.74-0.310.51-0.830.80.480.810.830.880.930.80.820.740.80.460.78-0.710.8-0.20.89-0.590.830.240.850.510.990.89
0.930.89-0.530.74-0.940.930.730.860.910.950.90.840.890.820.890.420.86-0.80.94-0.190.95-0.640.920.250.940.540.90.89
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
Competition

According to the company's disclosures, Insmed Inc has a Z Score of -2.41. This is 135.7% lower than that of the Biotechnology sector and 172.16% lower than that of the Health Care industry. The z score for all United States stocks is 127.64% higher than that of the company.

Insmed Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Insmed's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Insmed could also be used in its relative valuation, which is a method of valuing Insmed by comparing valuation metrics of similar companies.
Insmed is currently under evaluation in z score category among related companies.

Insmed Institutional Holders

Institutional Holdings refers to the ownership stake in Insmed that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Insmed's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Insmed's value.
Shares
Geode Capital Management, Llc2023-12-31
3.1 M
Suvretta Capital Management, Llc2023-12-31
2.7 M
Bank Of New York Mellon Corp2023-12-31
2.4 M
Loomis, Sayles & Company Lp2023-12-31
2.3 M
Bellevue Group Ag2023-12-31
2.3 M
Ameriprise Financial Inc2023-12-31
2.3 M
Alliancebernstein L.p.2023-12-31
2.1 M
Pictet Asset Manangement Sa2023-12-31
M
Rtw Investments, Llc2023-12-31
1.9 M
Vanguard Group Inc2023-12-31
14.1 M
Blackrock Inc2023-12-31
11.5 M

Insmed Fundamentals

About Insmed Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Insmed Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Insmed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Insmed Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey. Insmed operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 613 people.

Insmed Investors Sentiment

The influence of Insmed's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Insmed. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Insmed's public news can be used to forecast risks associated with an investment in Insmed. The trend in average sentiment can be used to explain how an investor holding Insmed can time the market purely based on public headlines and social activities around Insmed Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Insmed's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Insmed's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Insmed's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Insmed.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Insmed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Insmed's short interest history, or implied volatility extrapolated from Insmed options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:
Check out Insmed Piotroski F Score and Insmed Valuation analysis.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Complementary Tools for Insmed Stock analysis

When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEOs Directory
Screen CEOs from public companies around the world
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.34)
Revenue Per Share
2.173
Quarterly Revenue Growth
0.411
Return On Assets
(0.28)
Return On Equity
(14.53)
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.